Literature DB >> 3280286

[Anticytoplasmic antibodies as serological markers and activity parameters of Wegener's granulomatosis. A prospective study].

G Lüdemann1, B Nölle, A Rautmann, S Rosenboom, J Kekow, W L Gross.   

Abstract

Sera from 105 patients with Wegener's granulomatosis (WG) and 1,500 control subjects (with, among other diseases, primary or secondary vasculitis, collagen disease, glomerulonephritis or various granulomas) were examined with respect to sensitivity, specificity and importance of anticytoplasmic antibodies (ACPA) as markers of disease activity. The antibodies were demonstrated in 77 of the 105 patients (73%) with WG and six of the controls (less than 1%). They were always present in active WG (57 patients). In a prospective study of 21 closely followed patients with WG there was a close correlation between ACPA titre and the disease activity as measured by clinical and biochemical criteria. After induction of remission there was in all instances a clear fall in titre, while the titre rose again on exacerbation but remained unchanged during superinfection. Thus anticytoplasmic antibodies are useful both in primary diagnosis and in estimating disease activity of WG.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3280286     DOI: 10.1055/s-2008-1067654

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  5 in total

Review 1.  Significance of antibodies to cytoplasmic components of neutrophils.

Authors:  U Specks; R A DeRemee
Journal:  Thorax       Date:  1989-05       Impact factor: 9.139

Review 2.  Wegener's granulomatosis. Thoughts and observations of a pathologist.

Authors:  F Wegener
Journal:  Eur Arch Otorhinolaryngol       Date:  1990       Impact factor: 2.503

Review 3.  Antineutrophil cytoplasmic antibodies (ANCA) and vasculitis.

Authors:  C G Kallenberg
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

4.  Stage-adapted treatment of Wegener's granulomatosis. First results of a prospective study.

Authors:  D Steppat; W L Gross
Journal:  Klin Wochenschr       Date:  1989-07-03

5.  Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme.

Authors:  J Lüdemann; B Utecht; W L Gross
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.